Item 9 Labs (OTC:INLB) Stock Price Up 23.5%
Item 9 Labs (OTC:INLB) Stock Price Up 23.5%
Shares of Item 9 Labs Corp. (OTC:INLB – Get Rating) were up 23.5% during trading on Friday . The stock traded as high as $0.21 and last traded at $0.21. Approximately 15,915 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 18,450 shares. The stock had previously closed at $0.17.
Item 9 Labs Price Performance
The company has a market capitalization of $20.79 million, a P/E ratio of -0.84 and a beta of 0.55. The business's 50-day moving average is $0.26 and its two-hundred day moving average is $0.45. The company has a quick ratio of 0.04, a current ratio of 0.14 and a debt-to-equity ratio of 0.02.
About Item 9 Labs
(Get Rating)
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
Featured Articles
- Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.
Item 9 Labs Corp.(場外交易代碼:INLB-GET評級)的股價在週五的交易中上漲了23.5%。該股一度漲至0.21美元,最後報0.21美元。午盤交易中,約有15,915股股票成交,較18,450股的日均成交量下降了14%。該股此前收盤價為0.17美元。
第9項實驗室性價比
該公司市值為2,079萬美元,本益比為-0.84,貝塔係數為0.55。該業務的50日移動均線切入位在0.26美元,200日移動均線切入位在0.45美元。該公司的速動比率為0.04,流動比率為0.14,債務權益比率為0.02。
關於第9項實驗
(獲取評級)
第九項實驗室公司在美國是一家垂直整合的大麻運營商和藥房特許經營商。該公司生產各種類別的大麻和大麻相關產品,如鮮花、濃縮物、蒸餾液和五金製品。它通過獲得許可的藥房向亞利桑那州的消費者提供大麻和大麻衍生產品和技術。
專題文章
- 免費獲取StockNews.com關於第9項實驗室的研究報告(INLB)
- MarketBeat:回顧中的一週01/02-01/06
- 為什麼CrowdStrike的股價舉步維艱?
- 2023年四隻被低估的醫療保健股票
- WWE股票:文斯·麥克馬洪想要重返節目
- NVIDIA正在觸底,但現在還不能買入
每天接收第九項實驗的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收關於Item 9實驗室和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧